Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report) shares saw an uptick in trading volume on Friday . 15,469 shares changed hands during mid-day trading, an increase of 72% from the previous session’s volume of 8,984 shares.The stock last traded at $17.02 and had previously closed at $16.00.
Analyst Ratings Changes
Several equities research analysts recently commented on the company. UBS Group assumed coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research report on Friday, November 15th. They set a “buy” rating and a $21.00 target price on the stock. William Blair raised shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th.
Check Out Our Latest Report on TLX
Telix Pharmaceuticals Limited American Depositary Shares Trading Up 4.9 %
Telix Pharmaceuticals Limited American Depositary Shares Company Profile
Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.
Featured Stories
- Five stocks we like better than Telix Pharmaceuticals Limited American Depositary Shares
- Why Invest in 5G? How to Invest in 5G Stocks
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- 3 Dividend Kings To Consider
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- What is the Euro STOXX 50 Index?
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.